Law360
10 Global Challenges For Life Sciences Cos. In 2016
January 27, 2016
Life sciences companies face many challenges for 2016, including the demand to develop innovative products at reduced cost. More and more, this means that companies must assess opportunities in major markets across the globe and seek value-maximizing partnerships at all phases of the product life cycle, from development to manufacturing to marketing. The increasingly global and increasingly interconnected nature of the life sciences industry also means that companies must track litigation, policy, regulatory and enforcement developments in the U.S., EU, Asia and other major markets, and must also anticipate the ways in which these developments will impact business opportunities.
Contacts

Capabilities
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Swiss MedTech 2026Tuesday, August 25, 2026Bay Area Life Sciences RoundtableWednesday, July 22, 2026Sidley Shortlisted in 16 Categories at the LMG Life Sciences Americas Awards 2026July 20, 2026Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026OIG Signals Further Support for Manufacturer-Sponsored Testing Programs with Fourth Favorable Advisory OpinionJuly 8, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

